Home » Topics » Science » New compound

New compound
RSS

New PDE III/IV inhibitor described

March 10, 1997

Dual NEP/ECE inhibitor for heart failure

March 6, 1997

Potential agent for hypertension and CHF from Roche Bioscience

March 6, 1997

Zeneca presents potent and selective ETA receptor antagonist

March 6, 1997

Glaxo Wellcome evaluates melatonin agonist

March 6, 1997

Abbott describes AK inhibitor with anticonvulsant/neuroprotective effects

March 6, 1997

Selective, nonpeptide inhibitor of Ras farnesylation discovered by Schering-Plough

March 6, 1997

Orally active inhibitor of Ras farnesylation reported by Schering-Plough

March 5, 1997

Selective stromelysin-1 inhibitor described by Merck & Co.

March 5, 1997

Candidate proton pump inhibitor described by Dainippon

Feb. 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...